In this Issue:
Impact of selective and nonselective beta-blockers in patients with ovarian cancer
Effectiveness of IP/IV chemotherapy for treatment of ovarian cancer
Impact of age and primary disease site on outcome in women with LGSOC or LGSPC
Olaparib monotherapy after carboplatin/ paclitaxel in patients with advanced breast, ovarian or fallopian tube cancer
TDTE in ovarian cancer patients who underwent diaphragmatic surgery
Laparoscopic surgery in EOC patients after neoadjuvant chemotherapy OCEANS trial final OS and safety analysis
Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab
Hypoalbuminaemia and post-operative complication rate and OS in patients with EOC undergoing cytoreductive surgery
Pazopanib + paclitaxel vs paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer
PD-1 blockade in tumours with mismatch-repair deficiency
Please login below to download this issue (PDF)